What is a Discussion Group? | Problems Using Discussion Group? | Changing E-mail Address? |
---|
![]() |
The Pharmaceutical Sci-Tech Discussion Group is designed to provide a vehicle for the free exchange of information in the areas of international pharmaceutical manufacturing, quality control, process validation and regulatory affairs, emphasizing but not limited to, sterile products technology. The discussion group is open to anybody with an interest in pharmaceutical science and technology.
This discussion group is sponsored and moderated by (PDA), an international association for pharmaceutical science and technology, located in Bethesda, Maryland, USA. PDA is an 8,500+ member international non-profit professional association which annually sponsors many meetings and educational courses, and publishes the bi-monthly PDA Journal of Pharmaceutical Science and Technology and the monthly PDA Letter.
Messages can be viewed either via the archive (access below) or by e-mail (you must first sign-up, see below).
Frequently asked questions (FAQ).
Enter keywords separated by a space
More Detailed Searching and Help |
You can contribute by sending an e-mail message to PharmTech@pharmweb1.man.ac.uk.
Please remember to write your name and e-mail address at the bottom of your message Alternatively, use the form below:
Q: How do I join the Pharmaceutical Sci-Tech Discussion Group?
A: To join the e-mail discussion group, enter your name and e-mail address that you want discussion group messages sent to in the form above. You can also designate whether you prefer one daily digest or individual messages. After you enter the desired information, click "Submit information" and you should get a message back saying that you've been successfully signed up. If you don't have web access, you must send a message to Moderator@pda.org asking to be signed up, clearly indicating your name and email address you'd like mail sent to.
Q: How do I unsubscribe from the Group?
A: To unsubscribe from the Pharmaceutical Sci-Tech Discussion Group, enter your name and e-mail address that you want discussion group messages sent to in the form above. Remember to click the "Leave the Discussion Group" option before you hit "Submit information." If you get a message saying you were not found in the list of recipients, check the email address you entered. If you have further problems, email PharmWeb-Admin@man.ac.uk.
Q: How should I address mail I'd like to submit to the Group?
A: Send it to PharmTech@pharmweb1.man.ac.uk
Q: Is there any special way I should format my postings to this group?
A: Yes, include your first & last names at the end of your submission, along with your return email address. Also, make sure you include a subject line which is descriptive and succinct.
Q: Can I advertise my company's products & services?
A: Only if you are doing so as part of providing a helpful and meaningful answer to a question that a Group member has posed. Blatant advertising will be rejected. If you would like to advertise job vacancies you can do so on the PharmWeb Appointments section.
Q: Can I advertise meetings and courses my organization is having?
A: Only if your organization is a non-profit entity. Commercial listings will not be accepted. Conferences are best listed on the FIP conference listing
Q: What is the scope of this group?
A: The Pharmaceutical Sci-Tech Discussion Group is designed to provide a vehicle for the free international exchange of information related to pharmaceutical manufacturing and quality, including but not limited to development and formulation, quality control/quality assurance, engineering, process validation, training and regulatory affairs. Because the scope is so wide, plans are being made to subdivide the group in order to allow users to more efficiently target information of interest. The scope does not include the clinical use of pharmaceutical products. Postings judged by the moderator to be outside the scope will not be accepted.
Q: What is PDA's role?
A: PDA along with Pharmweb underwrite the cost of maintaining the group, including moderating and administration. The postings do not necessarily represent the position of PDA, and the authors are solely responsible for the accuracy of information provided.